NMC
AGRX

NEA Management Company’s Agile Therapeutics AGRX Stock Holding History

NEA Management Company’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67
Closed -$761K – 39
2016
Q4 		$761K Hold
67
– – 0.03% 36
2016
Q3 		$932K Hold
67
– – 0.04% 37
2016
Q2 		$1.02M Hold
67
– – 0.05% 37
2016
Q1 		$829K Hold
67
– – 0.06% 37
2015
Q4 		$1.3M Hold
67
– – 0.08% 33
2015
Q3 		$900K Hold
67
– – 0.06% 34
2015
Q2 		$1.15M Hold
67
– – 0.06% 34
2015
Q1 		$1.24M Buy
67
+2
+3% +$35.1K 0.06% 35
2014
Q4 		$802K Buy
65
+50
+333% +$635K 0.04% 34
2014
Q3 		$218K Buy
15
+4
+36% +$61.8K 0.01% 34
2014
Q2 		$191K Buy
+11
New +$159K 0.01% 30

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

NEA Management Company's AGRX Position: Q1 2017 in Review

NEA Management Company sold out of Agile Therapeutics (AGRX) in Q1 2017, closing a stake of 67 shares — an estimated $761K sold.

NEA Management Company first reported a position in AGRX in Q2 2014 and held it in 11 quarters. The position peaked at $1.3M in Q4 2015. 48 funds tracked by Wall St. Rank hold AGRX as of Q1 2017.

  • NEA Management Company reported no remaining Agile Therapeutics position as of Q1 2017 after selling out during the quarter.
  • NEA Management Company sold 67 Agile Therapeutics shares in Q1 2017, an estimated $761K.
  • NEA Management Company first reported a position in Agile Therapeutics in Q2 2014 and held it in 11 quarters.
  • NEA Management Company's Agile Therapeutics position peaked at $1.3M in Q4 2015.
  • 48 funds tracked by Wall St. Rank held Agile Therapeutics as of Q1 2017.

Based on NEA Management Company's 13F filing for Q1 2017, filed 10 May 2017.